Thyroid Carcinoma clinical trials

Explore recruiting thyroid carcinoma clinical trials.

Recruiting thyroid carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thyroid Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of metformin effect on the fertility of women treated with 131I for thyroid cancer

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Digoxin for the Reinduction or Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Network pharmacology-based personalized drug repurposing in thyroid carcinoma: a pilot feasibility trial

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Prospective, multicenter, randomized study on combined LT4 + LT3 therapy versus LT4 in the control of TSH in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Prostate-specific membrane antigen in thyroid and head and neck carcinoma: On the utility of [18F]AlF-PSMA-11 PET in advanced disease

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter, open label, two cohort, single arm, phase II study to evaluate the efficacy and safety of the anti-TROP-2 antibody-drug conjugate sacituzumab govitecan in patients with advanced differentiated and anaplastic thyroid neoplasms.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Thyroid Carcinoma trials by city

Thyroid Carcinoma in Toronto Thyroid Carcinoma in Vancouver Thyroid Carcinoma in Montreal Thyroid Carcinoma in Calgary Thyroid Carcinoma in Edmonton Thyroid Carcinoma in Ottawa Thyroid Carcinoma in Winnipeg Thyroid Carcinoma in Quebec City Thyroid Carcinoma in Hamilton Thyroid Carcinoma in Kitchener Thyroid Carcinoma in London Thyroid Carcinoma in Halifax Thyroid Carcinoma in New York Thyroid Carcinoma in Los Angeles Thyroid Carcinoma in Chicago Thyroid Carcinoma in Houston

Thyroid Carcinoma clinical trials

Recruiting thyroid carcinoma studies right now

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

TRAIL Study: Feasibility and Pilot

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study

A Prospective Trial Comparing Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) and Conventional Open Thyroidectomy

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy

Also recruiting in Europe

Evaluation of metformin effect on the fertility of women treated with 131I for thyroid cancer

Digoxin for the Reinduction or Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma.

Network pharmacology-based personalized drug repurposing in thyroid carcinoma: a pilot feasibility trial

Prospective, multicenter, randomized study on combined LT4 + LT3 therapy versus LT4 in the control of TSH in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors.

Prostate-specific membrane antigen in thyroid and head and neck carcinoma: On the utility of [18F]AlF-PSMA-11 PET in advanced disease

A multicenter, open label, two cohort, single arm, phase II study to evaluate the efficacy and safety of the anti-TROP-2 antibody-drug conjugate sacituzumab govitecan in patients with advanced differentiated and anaplastic thyroid neoplasms.

Thyroid Carcinoma trials by city

Other conditions